What Is the Prognosis for Mesothelioma Patients?
1:12

Expert Take

Dr. Andrea Wolf: What is the prognosis for mesothelioma patients

The prognosis for mesothelioma patients is not as good as it is with some other cancers that you hear about, such as breast or prostate cancer in most cases, but it is not nearly as bad as is often portrayed. And so what I try to convey to patients is a lot of this is based on all comers. And many patients with mesothelioma present or come to attention and are diagnosed very late in the game.

Especially in people who are diagnosed earlier, people with early-stage disease, and certain types and certain factors that contribute to that prognosis are very individual. And how any one person does is very specific to that person, not some large data set. So while it's a difficult and challenging disease, the prognosis is variable. And people need to stay positive in order to become those patients who live long term because we have those.

What Is the Prognosis for Mesothelioma?

While the prognosis for mesothelioma is serious, no two mesothelioma patients are the same. Many factors determine a person’s outlook, including cancer type, stage at diagnosis, treatment choices and overall health. Survival varies widely based on those factors.

Mesothelioma Prognosis at a Glance

  • About 15% of patients live 5 years or longer.
  • Epithelioid cell type, early-stage diagnosis and being under 50 are factors associated with more favorable outcomes.
  • In our 2025 patient survey, 11% of people with mesothelioma reported being in remission or cancer-free. All had received treatment.
  • New treatments approved in 2024 and 2025 offer hope.
  • Surgery eligibility improves outcomes, but only about 20% of patients qualify.

Treatment significantly changes outcomes for people with mesothelioma. With treatment, most people with mesothelioma live 1 to 2 years after receiving their diagnosis. Without it, life expectancy drops to 6 to 8 months. Treatment advances, including new immunotherapy drugs like Keytruda (pembrolizumab) combined with chemotherapy, have improved survival rates. Early diagnosis and aggressive care often lead to a better prognosis.

Mesothelioma Prognosis: With Treatment vs. Without Treatment
Situation Typical Survival Notes
With treatment (all types) 12 to 24 months Multimodal therapy improves outcomes
Without treatment 6 to 8 months Palliative care can manage symptoms
With treatment — peritoneal, surgery + HIPEC eligible 4 to 5 years Highest survival rates of all mesothelioma types
With treatment — pleural, early stage 2+ years Stage 1 and 2 patients who undergo lung-sparing surgery

Mesothelioma Prognosis by Type

Peritoneal and testicular mesothelioma generally offer the most favorable prognosis, while pleural and pericardial tend to have poorer outlooks. Treatment access, particularly surgery eligibility, drives most of these differences. The Centers for Disease Control and Prevention notes that tumor origin defines the type of mesothelioma a person has.

Kasie Coleman, diagnosed with peritoneal mesothelioma in 2010, tells us her cancer went into remission in 2012. She underwent several cycles of chemotherapy and HIPEC treatments.

Survivor Experience

Before you begin to fight, you must first arm yourself with the right tools. Get your mind right. It’s extremely hard to develop a positive attitude when possibly facing death, but it’s possible. I decided that although the statistics were horrible, I was going to be the exception.”

Kasie Coleman
Kasie Coleman , peritoneal mesothelioma survivor
Verified Asbestos.com Survivor

Pleural Mesothelioma Prognosis

Pleural mesothelioma is the most common type, forming in the lining of the lungs. Only about 20% of people with pleural mesothelioma qualify for surgery, which is the single biggest contributing factor to its less favorable outcomes compared to other types. About 12% of people with pleural mesothelioma live 5 years or more, but those with an early-stage diagnosis who undergo aggressive, lung-sparing surgery often live 2 years or longer.

A 2022 study in the journal Cancers reported patients with stage 1 or 2 pleural mesothelioma had a median survival of 32.1 months. Early detection combined with multimodal treatment, including surgery, chemo and immunotherapy, is key in improving outcomes.

Pleural vs Peritoneal Mesothelioma Prognosis
Type Average Survival 5-Year Survival Rate
Pleural Mesothelioma 12 to 18 months Around 12%
Peritoneal Mesothelioma 4 to 5 years 47 to 52%

Peritoneal Mesothelioma Prognosis

Peritoneal mesothelioma has the most favorable prognosis of all types because it responds exceptionally well to tumor-removing surgery paired with heated intraperitoneal chemotherapy. About 47% to 52% of patients who receive surgery with HIPEC survive at least 5 years after diagnosis.

HIPEC helps control the cancer better than other treatments alone. People with peritoneal mesothelioma often experience longer survival and better quality of life when they receive care at specialized centers. Survivor Tamron Little has lived more than 18 years since her diagnosis and aggressive surgery. She now advocates for patients facing similar diagnoses.

What Tamron Little Wished She Had Known When Receiving a Mesothelioma Diagnosis

Survivor Story

Tamron Little: What I Wish I Knew When I Received My Mesothelioma Diagnosis

One thing that I wish I would have known when I was diagnosed that I know now is that you can survive and have a thriving life after mesothelioma.

All of the things that I was reading was giving me poor prognosis, so I wish I would have known that from the start because I could have handled it better than I did from the beginning.

Pericardial Mesothelioma Prognosis

Pericardial mesothelioma is very rare, affecting the lining around the heart. It has the poorest outlook, with most patients surviving only 2 to 6 months after diagnosis. Treatment options are limited, but chemo or surgery can sometimes extend survival. Few patients live beyond a year, making this the most challenging mesothelioma type. Because of its rarity, detailed prognosis data is limited.

Testicular Mesothelioma Prognosis

Testicular mesothelioma is also rare but tends to have a better outlook than other types. Patients who undergo surgery have a median survival of about 4 years. Around 50% reach the 5-year mark. Some have lived more than 10 years. Surgery often successfully controls this cancer type when caught early.

500+ SPECIALISTS AVAILABLE
Get to the Right Doctor, Faster

Connect with top-rated doctors specializing in mesothelioma treatment, who will personalize treatment options based on your diagnosis.

Find Your Doctor

Mesothelioma Prognosis by Stage (I–IV)

Staging is one of the most critical factors in mesothelioma prognosis. Generally, the earlier the stage at diagnosis, the better the outlook. Early-stage diagnosis combined with aggressive, lung-sparing surgery leads to these better outcomes. While the prognosis for stage 4 is poorest, some stage 4 patients defy odds and live longer with palliative care and targeted treatments.

It’s important to remember every patient is different, and outcomes can vary widely. People with advanced stage mesothelioma may live longer with successful treatment. Seeking expert care can ensure you receive personalized care optimized for you, potentially extending survival and improving quality of life.

Mesothelioma Prognosis by Stage
Stage Life Expectancy 2-Year Survival 5-Year Survival Surgery Eligibility
Stage 1 19 to 22 months About 39% About 22.5% Most patients qualify; cancer is still localized
Stage 2 About 19 months About 38% About 11% Some patients qualify with multimodal therapy
Stage 3 About 16 months About 34% About 16% Less likely to qualify as cancer spreads further
Stage 4 13 to 15 months About 25% About 7% Rarely qualify even with multimodal therapy
Source: Asbestos.com
Personalized Treatment & Prognosis

Exclusive Content

Sean Marchese, RN: How will personalized treatment help a mesothelioma patient’s prognosis?

By making treatment options more personalized to a specific patient’s type of cancer, where the cancer is, how they’ve responded to treatment in the past. It means that doctors can go in and look and see what potential avenues they can explore that haven’t been explored before. It improves the prognosis of these patients because now there are options that they know will have a better chance of success before trying other types and failing.

Other Factors That Affect Mesothelioma Prognosis

In addition to stage and mesothelioma type, other factors affecting mesothelioma prognosis include age, gender and overall health. Younger people and women tend to have better outcomes. Those with co-existing health conditions or otherwise poor health tend to have poorer outlooks. 

While you can’t control factors like your tumor cell type, you can improve your personal prognosis with mesothelioma treatment. Pleural mesothelioma survivor Michael Cole shares his firsthand experience of treatment, sharing, “I believe that the aggressive treatment I had in the beginning was absolutely necessary to give me a chance to be here now. And I am grateful for the decision that we made.”

Expert Insight

I’ve treated many mesothelioma patients over the years, and the treatments for it can be tough. Many times, aggressive treatment is necessary to extend their lives and improve their quality of life.

Small headshot of Dr. Jacques Fontaine.
Dr. Jacques Fontaine , board-certified thoracic surgeon
Factors That Affect Mesothelioma Prognosis
Factor Generally Favorable Often Less Favorable What to Know
Tumor location Peritoneal or testicular Pleural or pericardial Peritoneal mesothelioma has the highest survival rates and responds well to surgery combined with HIPEC. Pericardial is the rarest and most difficult to treat early.
Stage 1 or 2 3 or 4 Earlier-stage disease offers more treatment options, including surgery. But patients at every stage have options, and some later-stage patients respond well to immunotherapy or clinical trials.
Cell type Epithelioid Sarcomatoid or biphasic Epithelioid cells respond best to treatment. Biphasic tumors contain a mix of cell types, so outcomes vary depending on the ratio.
Age Under 50 75 or older Younger patients are more likely to tolerate aggressive treatment. But age alone doesn’t determine eligibility. Doctors weigh overall health and fitness for surgery more than age.
Gender Women Men Women tend to live longer with mesothelioma, particularly with peritoneal disease. Researchers are still studying why this difference exists.
Overall health Active, no chronic illness Significant coexisting conditions Patients in good general health can usually access a wider range of treatments. Chronic conditions like heart disease or reduced lung function can affect which options are on the table.
Treatment Multimodal therapy No treatment or palliative care only Combining surgery, chemotherapy, immunotherapy and/or radiation tends to produce the best outcomes. Palliative care alone focuses on quality of life and comfort rather than extending survival.

Cell Type

Cell type is one of the strongest predictors of how mesothelioma responds to treatment. There are 3 mesothelioma cell types, each with meaningfully different outlooks. The third type is a combination of the others.

Mesothelioma Cell Types Can Affect Prognosis

  • Epithelioid: This is the most common cell type and it responds best to treatment. People with epithelioid tumors tend to live longer because these cells grow more slowly and stay localized longer.
  • Sarcomatoid: This type grows quickly and spreads early. It often responds poorly to standard treatment, though immunotherapy is helping improve prognoses. 
  • Biphasic: This type is a mix of epithelioid and sarcomatoid cells. Outcomes often vary depending on which cell type outnumbers the other.

Knowing your mesothelioma cell type helps your doctor select the most effective treatment plan for you. This information helps your doctor better understand the complex combination of factors that may influence your outlook.

Patient and Demographic Factors

Certain patient characteristics can also affect how well someone with mesothelioma may respond to treatment. These factors can influence overall prognosis and survival.

Important Factors That Can Influence Prognosis and Survival

  • Age: Patients under 50 often have better outcomes as they’re more likely to qualify for and tolerate aggressive treatments.
  • Gender: Women tend to live longer than men with mesothelioma, though researchers are still studying the reasons for this difference.
  • Overall health: People with active lifestyles and no chronic illnesses tend to tolerate treatment better.
  • Race: Black patients show a higher 5-year survival rate (21.3%) compared to white patients (13.9%) in some studies, according to SEER.

Statistics offer broad patterns, but individual outcomes often surprise doctors. Susan Dickman proved that persistence and the right mesothelioma surgeon could overcome both her age and advanced diagnosis. Diagnosed at 72 with stage 4 peritoneal mesothelioma, Susan was initially told she wasn’t a surgery candidate, but she refused to accept palliative care as her only option. More than a decade since her tumor-removing surgery, Susan says she hasn’t had a recurrence and “Life is good.”

FREE NUTRITION GUIDE + JOURNAL
Nutrition Tips and Recipes for Mesothelioma

Access expert diet and exercise guidance designed specifically for mesothelioma patients to support treatment and overall wellness.

Get Your Free Guide

Can Mesothelioma Go Into Remission?

While there is no cure for mesothelioma, remission does happen. In our 2025 survey, 11% of patients who told us their doctor said they’re in remission or cancer-free. All of those in remission had received treatment including surgery (23%) and a combination of chemo and surgery (76%). 

Mesothelioma type also affected remission rates. Of patients with peritoneal mesothelioma,  16% reported remission compared to 8% of those with pleural mesothelioma.

Mesothelioma Patients Reported Remission

11%

Source: The Mesothelioma Center, 2025

Patients in Remission had Treatment

100%

Source: The Mesothelioma Center, 2025

These findings show remission is possible with tailored treatment, underscoring the importance of expert mesothelioma care. Every patient’s journey is unique, and thanks to advances in therapies and approaches, there’s hope for those coping with a mesothelioma diagnosis

Dr. Andrea Wolf, who directs the New York Mesothelioma Program at Mount Sinai, helps many people with mesothelioma improve their prognosis. Dr. Wolf tells us, “I’m realistic. And there is good reason today to be optimistic. We can help these patients. We’ve proven that. They can live with mesothelioma if treated effectively.”

What We Were Told About My Dad's Mesothelioma Prognosis

Mesothelioma Caregiver

Kim Snyder: What We Were Told About My Dad’s Mesothelioma Prognosis

Before the surgery, there was just, like, if he did nothing, it was probably gonna be, like, six months maybe if he did nothing, maybe nine at the most.

With having the surgery, then they would have been able to extend it, you know, maybe, like, a year, eighteen months.

And, but, yeah, without doing anything, it would probably only been about six months or so.

How to Improve Your Mesothelioma Prognosis

Seeing a specialist, pursuing multimodal therapy and considering clinical trials are among the most impactful steps a person with mesothelioma can take. Maintaining overall health through diet and exercise can also make a meaningful difference in survival and quality of life.

5 Tips for Improving Your Mesothelioma Prognosis

  1. Ask about multimodal therapy: Multimodal therapy combines surgery, chemo and/or immunotherapy to target cancer in different ways. People often see better results with a combination of treatments.
  2. Consider palliative and supportive care: Palliative care helps people with mesothelioma manage symptoms like pain. Supportive care addresses your physical and mental health needs from side effect management to support groups and counseling.
  3. Find a mesothelioma specialist: A mesothelioma specialist has experience treating this rare cancer and can offer access to clinical trials, newer therapies and specialized surgical techniques that general hospitals don’t provide, all of which can make a real difference in your treatment plan and outlook.
  4. Make healthier lifestyle choices: Gentle exercise and a balanced diet can help. They can reduce side effects and improve mesothelioma symptoms. 
  5. Participate in a clinical trial: Clinical trials offer access to cutting edge therapies that may improve your outlook.

Michael Cole tells us he was very active before his diagnosis, but it was challenging to exercise after surgery. He shares, “Exercise is very important to keeping our strength up and our bodies working correctly. In my experience, it can also be one of the hardest things to do. After my extrapleural pneumonectomy surgery they had me up walking within a very short period of time. It was hard, and I really didn’t want to do it, but they told me if I did not I would die. Not a bad motivator. Since then, my wife has helped motivate me to exercise, even when I do not want to.”

Asbestos.com Expert Takeaway
Expert Takeaways on Mesothelioma Prognosis
  • Research suggests that heated chemo after pleurectomy decortication surgery may improve overall survival compared to surgery alone.
  • Average prognosis reflects general statistics. Predicting an individual’s treatment response is difficult. Overall health and lifestyles play a role. Your prognosis is personal.
“The prognosis for mesothelioma is not as grim as often portrayed. Many factors affect the journey, ranging from the patients to the options on treatments that patients chose. It’s important for patients to stay positive and to know that long-term survivors do exist.”
Catherine Perrault headshot

Dr. Catherine Perrault, medical officer and board-certified family physician with The Mesothelioma Center’s Medical Outreach Team

Mesothelioma Prognosis: Frequently Asked Questions

We asked The Mesothelioma Center’s team of Patient Advocates what patients ask about mesothelioma prognosis when they call us. They’ve shared these questions along with their helpful answers.

How long can I live with mesothelioma?

Most people with mesothelioma live 12 to 24 months with treatment. Without treatment, survival often is measured in months, usually 6 to 8. Some patients live for many years, even more than a decade, especially when working with experienced mesothelioma specialists.

Can mesothelioma go into remission?

Yes, remission can happen. In our 2025 survey, 11% of mesothelioma patients reported their doctors told them they were in remission or cancer-free. All those patients had received treatment, showing that active care can lead to remission.

Can mesothelioma come back after treatment?

Mesothelioma can return after treatment. The cancer may be controlled but not completely cured. Regular follow-ups are essential to catch any signs of mesothelioma recurrence early.

How can a mesothelioma specialist improve my prognosis?

Mesothelioma specialists have experience treating this rare cancer. They can offer the latest therapies, tailor care plans to your needs, and help you access clinical trials. Working with a specialist often improves both prognosis and quality of life.

What is the difference between mesothelioma prognosis and life expectancy?

Mesothelioma prognosis is a doctor’s broader clinical assessment of how a person’s cancer will likely progress, covering treatment response, quality of life and overall disease course. Life expectancy refers specifically to survival duration in months or years. Prognosis informs life expectancy estimates but encompasses more than survival time alone.

What factors give mesothelioma a better prognosis?

Several factors contribute to a more favorable mesothelioma prognosis, including an early-stage diagnosis (Stage 1 or 2), epithelioid cell type, peritoneal tumor location, being a woman, younger age at diagnosis and good overall health. Choosing treatment, particularly multimodal therapy, also significantly improves outcomes. Patients can’t control all of these factors, but treatment decisions can make a meaningful difference.

Recommended Reading